Stockscreener 앱 받기
14.51
1.33%
0.19
시간 외 거래:
14.81
0.30
+2.07%
Biohaven Ltd 주식(BHVN)의 최신 뉴스
How Biohaven’s (BHVN) Trade Secret Verdict Shapes Its Intellectual Property Defense Strategy - simplywall.st
Federal jury awards Yale University, Biohaven $4M in trade secret suit - Westfair Communications
Yale, Biohaven Win $4M In Biotech Trade Secret Trial - Law360
Yale, Biohaven Win $4 Million Verdict Over Drug-Development Tech - Bloomberg Law News
Federal jury awards Yale, Biohaven $4M in lawsuit over trade secrets - Hartford Business Journal
Biohaven and Yale win $4M verdict in trade secret case - Investing.com Canada
Federal Jury Finds Avilar Therapeutics and RA Capital Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Awards Biohaven and Yale University $4 Million - PR Newswire
Biohaven Ltd (BHVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Biohaven Ltd (BHVN) Institutional Confidence - TradingKey
Biohaven Ltd (BHVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Biohaven Ltd (BHVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BHVN|Biohaven Ltd|Price:14.320|Chg%:-0.320 - TradingKey
BHVN|Biohaven Ltd|Price:14.563|Chg%:+0.243 - TradingKey
Biohaven Ltd (BHVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Biohaven Ltd. Revenue Breakdown – NYSE:BHVN - TradingView
Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 53% Potential Upside in the Biotech Sector - DirectorsTalk Interviews
Biohaven Pharmaceutical Holding Company Ltd (BHVN) Earnings, Actual EPS, EPS Estimates & Results - Stocktwits
Biohaven to Present New Clinical Data at ESMO Congress on BHV-1530, a Novel FGFR3-Directed ADC With a Proprietary Topoisomerase I (TopoIx) Payload - Finansavisen
How Biohaven’s (BHVN) R&D Leadership Shuffle Will Impact Investors - simplywall.st
Biohaven Ltd. (NYSE: BHVN) legal chief discloses holdings - Stock Titan
Lobbying Update: $120,000 of BIOHAVEN LTD. lobbying was just disclosed - Quiver Quantitative
Biohaven files Form 3 for Chief Legal Officer Warren Karl Volles - Bitget
Price to book forward of Biohaven Ltd. – NYSE:BHVN - TradingView
Discipline and Rules-Based Execution in BHVN Response - Stock Traders Daily
Biohaven (BHVN) 10K Form and Latest SEC Filings 2026 - MarketBeat
Price to earnings forward of Biohaven Ltd. – BOATS:BHVN - TradingView
Biohaven Research Ltd Shs Unsponsored Brazilian Depositary Receipt Repr 0.33333333 Shs - TradingView
Biohaven: Nice Pipeline Momentum, But Its Runway Is A Risk (NYSE:BHVN) - Seeking Alpha
Enterprise value to EBIT forward of Biohaven Ltd. – BOATS:BHVN - TradingView
Price to sales forward of Biohaven Ltd. – NYSE:BHVN - TradingView
Price to sales forward of Biohaven Ltd. – BOATS:BHVN - TradingView
Biohaven to Present at the 43rd Annual J.P. Morgan Healthcare Co - GuruFocus
Biohaven (BHVN) Advances Key Trials Following Pipeline Progress While Valuation Still Looks Pricey - Sahm
Enterprise value to revenue forward of Biohaven Ltd. – NYSE:BHVN - TradingView
BHVN News | BIOHAVEN LTD (NYSE:BHVN) - ChartMill
Biohaven announces leadership changes - Hartford Business Journal
Biohaven Announces Scientific Leadership Changes - Contract Pharma
ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership - Yahoo Finance
Is Biohaven’s (BHVN) R&D Shake-Up Quietly Redefining Its Late-Stage Pipeline Strategy? - Yahoo Finance
Biohaven Announces Scientific Leadership Transitions - GuruFocus
Biohaven Chief Scientific Officer Bruce Car to Transition to Chief Innovation Officer - Moomoo
Biohaven: Bruce Car, Transitioning From Chief Scientific Officer to Chief Innovation Officer Focusing on External Collaborations >BHVN - Moomoo
Biohaven Announces Leadership Changes to Accelerate CNS Drug Discovery and Innovation Through Bexorg Collaboration – Minichart - Minichart
Biohaven announces leadership changes in discovery unit By Investing.com - Investing.com India
Biohaven announces leadership changes in discovery unit - Investing.com
Biohaven (NYSE: BHVN) shifts CSO to innovation role, promotes discovery head - Stock Titan
Biohaven (BHVN) Completes Enrollment in RISE3 Trial - Yahoo Finance
BHVN Stock Builds Momentum Ahead Of Multiple H2 2026 Clinical Data Readouts - Yahoo Finance
Janus Henderson holds 8.58M Biohaven shares (BHVN) — 5.7% stake - Stock Titan
Biohaven (BHVN) Is Up 5.6% After Advancing Two Late-Stage Trials in Epilepsy and Graves’ Disease - simplywall.st
10 Best Performing American Stocks in June 2026 - Insider Monkey
Why Wall Street Is Growing More Cautious on Biohaven (BHVN) - Insider Monkey
BHVNBiohaven Ltd Latest SEC Filings - Finviz
Biohaven Shares Drop 9.8% to $14.28 - Intellectia AI
Biohaven (BHVN) Insider Trading Activity 2026 - MarketBeat
Does Advancing Opakalim and BHV-1300 to Pivotal Trials Change The Bull Case For Biohaven (BHVN)? - simplywall.st
1.97%
0.83%
자본화:
|
볼륨(24시간):